Acute Chest Syndrome


Article Author:
Amanda Friend


Article Editor:
Daniel Girzadas


Editors In Chief:
Chaddie Doerr


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Kyle Blair
Trevor Nezwek
Radia Jamil
Erin Hughes
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Navid Mahabadi
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Abbey Smiley
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Daniyal Ameen
Altif Muneeb
Beenish Sohail
Nazia Sadiq
Hajira Basit
Phillip Hynes
Komal Shaheen
Sandeep Sekhon


Updated:
11/15/2018 11:25:36 PM

Introduction

Acute chest syndrome (ACS) is the result of various inciting events causing vaso-occlusion within the pulmonary vasculature of patients with sickle cell disease (SCD). ACS can occur in any SCD phenotype. However, it is most common in HbSS. ACS can progress quickly and is the most common cause of death in patients with SCD. Therefore, it is important to make the diagnosis and begin treatment as soon as possible. [1][2][3]

Etiology

Bone marrow or fat emboli have been suspected to cause the majority of adult cases of ACS. Analysis of postmortem bronchoalveolar lavage in patients who died of SCD frequently reveals fat containing alveolar macrophages. Bone marrow ischemia and necrosis are characteristic of vaso-occlusive crises, which can result in the release of bone marrow and fat into the venous circulation. These particles can then travel to the lungs triggering vaso-occlusion and ACS.

Other causes of ACS include infection, asthma, hypoxemia, oversedation, and post-operative complications. In children, infection is often a common inciting event. Asthma exacerbated bronchospasms can lead to hypoxia, which leads to sickling. Patients with SCD and asthma are two to four times more likely to get ACS than patients with SCD alone. Chronic hypoxemia is seen in many patients, especially in children overnight. Of note, these patients can have normal oxygen saturation during the day but develop hypoxia at night, leading to sickling. Postoperative patients can have hypoventilation due to pain or medications that can cause sedation. Hypoventilation in these settings may precipitate sickling in the pulmonary circulation resulting in ACS. Patients with sickle cell disease are more likely to develop in situ thrombi in the pulmonary circulation rather than a pulmonary embolism. However, pulmonary embolism should still be considered if the patient has signs of an extremity deep venous thrombosis or a clinical picture suggestive of pulmonary embolism. [4][5]

Epidemiology

Acute chest syndrome is the most common acute pulmonary disorder in patients with sickle cell disease. Fifty percent of patients with SCD will have one episode of ACS. The peak incidence of ACS is in pediatric patients age 2 to 4 years. Within the adult population, 78% of ACS episodes are secondary to vaso-occlusive pain episodes. ACS is the most common cause of death among patients with SCD accounting for close to 25% of deaths. Adults with ACS have a 4.3% death rate, while children have a 1.1% death rate. [6]

Pathophysiology

A specific cause for ACS in children is found in approximately 40% of cases. Within this 40%, most are due to infections, with the next common causes being pulmonary infarction and fat embolism. Infectious causes most commonly are viral, mycoplasma pneumonia, or chlamydia pneumonia. 

In adult patients, half of the patients who develop ACS are initially admitted for other reasons, frequently vaso-occlusive crises (VOC). VOC, as discussed earlier, can result in bone marrow or fat emboli to the pulmonary circulation, the most common causes of ACS. VOC of the spine, ribs, and abdomen, have an additional risk. VOC in these body regions can lead to hypoventilation secondary to both pain and opioids, which then triggers hypoxemia/alveolar hypoxia and low arterial oxygen tension, resulting in sickling and ACS.

The pathophysiology of ACS is based on vaso-occlusion within the pulmonary microvasculature. Whatever the inciting event, deoxygenation of hemoglobin is the common next step in SCD leading to polymerization and sickling of erythrocytes. These sickled erythrocytes then cause further vaso-occlusion, ischemia, and endothelial injury.

Fat emboli are known to cause the release of free fatty acids (FFA) within the pulmonary vasculature due to phospholipase A2. FFA is very pro-inflammatory, which leads to pulmonary injury with resultant hypoxemia.[4][7]

History and Physical

The presentation of ACS varies between pediatric and adult patients. Pediatric patients are more likely to have an infectious cause and will therefore present with symptoms such as wheezing, cough, increased work of breathing, and fever. Adult patients are more likely to present with chest pain, pain in the arms and legs, shortness of breath, or a vaso-occlusive crisis elsewhere in the body (e.g., priapism).

Evaluation

The diagnosis of ACS depends on both radiographic evidence and clinical symptoms. To be diagnosed with ACS, a patient must meet the following criteria.[5][8]

  • New pulmonary infiltrates on chest imaging (chest x-ray, CT) involving at least one lung segment; this cannot be due to atelectasis and must have one of the following symptoms:
  1. Chest pain
  2. Temperature more than 38.5 C
  3. Tachypnea, wheezing, rales, coughing, appearance of an increased work of breathing
  4. Hypoxemia, relative to baseline (more than 2% decrease in SpO2 from steady state on room air, PaO2 less than 60 mmHg)

This algorithm lacks some specificity, and can also be diagnostic of pneumonia. It is very important to get a chest radiograph on every SCD patient with any respiratory symptoms since ACS can start insidiously, and it is important to start treatment early.

Risk Factors

  • Low HbF
  • Young age
  • Presence of asthma or other hyperreactive lung disorder
  • Smoking
  • Recent trauma or surgery

Treatment / Management

Clinicians must have a high suspicion for ACS during a VOC. Early treatment leads to lower mortality, shorter length of stay, reduced cost and less chance of recurrence. Once initiated, treatment of ACS must be aggressive since the disease process can escalate quickly. [9][10][11]

Acute management of ACS includes pain control, intravenous (IV) fluids, antibiotics, supplemental oxygen, and blood transfusions. Pain control for children normally starts with ketorolac, since it is nonsedating and less likely to cause hypoventilation than opioid pain medication. Adult pain management can also begin with ketorolac. Both pediatric and adult patients whose pain is not adequately controlled with ketorolac and acetaminophen will require opioid pain medication best delivered by a PCA (patient controlled anesthesia) device. Pain control in ACS is a balance between analgesia to prevent atelectasis and oversedation which can lead to hypoventilation and hypoxia. Fluid management is necessary in cases of dehydration since hypovolemia can cause additional sickling. Recommendations no longer advise large volume IV hydration, since overhydration can lead to pulmonary edema, which again leads to more respiratory complications. Fluid management should be directed by the patient’s hydration status. 

Broad-spectrum antibiotics should to given to every ACS patient. Infection is more likely in the pediatric population than in adult patients. However, in both groups, it is difficult to differentiate between ACS and pneumonia. Patients should be started on a third-generation cephalosporin (cefotaxime or ceftriaxone) for routine bacterial coverage and a macrolide (azithromycin or erythromycin) for atypical coverage.  If there is a concern for MRSA, vancomycin should be added. Treatment should last 7 to 10 days. Incentive spirometry should be done every 2 hours while awake to prevent atelectasis.

Supplemental oxygen should be given to correct a low SpO2 or PaO2. However, it is reasonable to give supplemental oxygen to any ACS patient because an appropriate oxygen saturation can mask possible focal hypoxemia. Co-oximetry is the most reliable way to monitor oxygen levels in SCD because patients have an oxyhemoglobin dissociation curve that is shifted to the right. Pulse oximetry can underestimate a patient’s oxygen pressure, and ABG can overestimate it. SpO2 should be kept above 92%, and PaO2 above 70 mmHg or no less than 3% below baseline. Of course, if supplemental oxygen is insufficient to correct hypoxemia, treatment can be escalated with BiPap, intubation, or ECMO as required.

Packed red blood cells (PRBC) transfusions have demonstrated some efficacy in case series. Unfortunately, no randomized controlled trials are evaluating PRBC transfusions versus supportive therapy for the management of ACS. Transfusions are given to improve oxygenation in ACS and have been shown to increase both SpO2 and PaO2. Blood transfusions are indicated when hemoglobin is 10% to 20% below baseline, less than 5 gm, a down trending hematocrit, if there is a worsening of radiographic signs, worsening symptoms, or if exchange transfusion is delayed. The goal of PRBC transfusion is to increase hematocrit to 30%, or Hg to 11.  Exchange transfusions are used in severe cases of ACS. Indications would include severe hypoxemia, multilobar disease on chest radiographs, or failure of blood transfusion.The goal of exchange transfusion is to increase hemoglobin to 10 and decrease HbS to less than 30%. Exchange transfusion allows hemoglobin to increase while avoiding hyperviscosity. When considering transfusion/exchange transfusion, consult with a hematologist.

Bronchodilators are indicated when there is underlying asthma. However, they can be administered in any case in which bronchospasm is identified or suspected. Steroids have been shown to shorten the length of stay but carry the risk of a higher rate of rebound VOC and increased risk of re-admission and increased risk of fat emboli. Bronchoscopy/BAL is only indicated if ACS is refractory to conventional treatment.[12]

Differential Diagnosis

  • Acute coronary syndrome
  • Acute MI
  • Pneumothorax
  • Pneumonia
  • Bilateral pleural effusions
  • Empyema
  • Aortic dissection
  • ARDS

Complications

  • ARDS
  • Respiratory failure
  • Pulmonary infarction
  • Severe pain
  • Death

Deterrence and Patient Education

Preventative Measures

Long-term management of ACS includes hydroxyurea, PRBC transfusions, and hematopoietic cell transplants. Hydroxyurea decreases the frequency of ACS by 50% in adults and 30% in kids. Hydroxyurea increases the concentration of HbF and is the only medication shown to decrease the incidence of ACS. Chronic transfusions can be used during the transition to hydroxyurea, in high-risk periods (winter), if hydroxyurea is inadequate, or if the patient is recovering from a life-threatening ACS. Risks of chronic transfusions include infection, iron overload, and allosensitization. Hematopoietic cell transplant has > 80% success and is indicated when the patient has had multiple episodes of ACS. This requires an HLA-matched sibling donor and carries all the risks associated with myeloablative regimens.

Long-term complications of repeated ACS include interstitial lung disease and pulmonary hypertension, however, the causation of this association is not well proven.

Pearls and Other Issues

New research for ACS is focused on both diagnosis and treatment. Serum phospholipase A2 converts neutral fats to FFA and has been shown to increase hours before the onset of ACS. This may be able to predict an ACS episode. Inhaled nitric oxide has a current ongoing randomized controlled trial regarding its efficacy. Inhaled NO is a pulmonary vasodilator, which should improve V/Q mismatching and decrease pulmonary hypertension. It may also increase the oxygen affinity of HbS, leading to less sickling of erythrocytes.

Enhancing Healthcare Team Outcomes

ACS is a serious complication of sickle cell anemia with high morbidity and mortality. Many of these individuals have repeated episodes of sickle cell crises, and thus it is important to prevent them with education. Besides the physician, the nurse and the pharmacist need to educate the patient on the importance of vaccination against pneumococcus. Patients admitted with ACS should be encouraged to use the incentive spirometer to prevent lung collapse. A pain consultant is often necessary for pain relief and reduces respiratory splinting, but the dose has to be titrated to avoid causing sedation. The hematologist should be consulted to assess the need for blood transfusions and plasma exchange. The pulmonologist should be consulted if the patient has asthma, COPD or restrictive lung disease as these disorders are associated with high morbidity in ACS. Even after a single episode of ACS, the patient and family should be educated about the importance of hydroxyurea, which is a potent inducer of HbF. The drug has been shown to lower the risk of sickle cell crises. Finally, the patient should be educated at discharge to return to the hospital is the symptoms worsen because the earlier the disorder is treated, the better is the outlook. [13][14][15](Level V)

Outcomes

ACS is a severe complication of sickle cell anemia and usually required admission. There are no randomized clinical trials on the treatment of ACS and outcomes. Anecdotal reports indicate fair to a good outcome in the short term, but repeated admissions are common. In addition, the syndrome is also associated with a high morbidity and mortality. Without aggressive treatment, poor outcomes are common. Patients must be started on hydroxyurea to prevent future episodes. [16][17](Level V)


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Acute Chest Syndrome - Questions

Take a quiz of the questions on this article.

Take Quiz
Which condition is associated with acute chest syndrome?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A mother brings her 16-year-old son, who is known to have sickle cell disease, to the emergency room with "difficulty breathing." He was well until approximately 1 week ago when he began having bilateral leg and arm pain, which are his usual sites for sickle cell pain. During the past evening, the pain worsened, and he also began having fevers to 101.6 F (38.6 C). The patient has had several past admissions for his sickle cell disease for vaso-occlusive crisis pain management. He has never received a blood transfusion. On physical exam, the patient is awake and alert, but clearly in pain. His sclerae are icteric bilaterally. He has a 3/6 systolic ejection murmur, and he has decreased breath sounds in his right lung base. His blood count reveals a white blood cell count of 16,500, with a hemoglobin of 6.5 g/dL. and a platelet count of 426,004. His differential has 65% neutrophils, 25% lymphocytes, 8% monocytes, and 2% eosinophils, and his reticulocyte count is 18.6%. A chest radiograph reveals a small fluffy infiltrate in the right lower lobe. At this time, the patient most likely has which of the following complications of sickle cell disease?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following should NOT be included in the management of acute chest syndrome?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Acute chest syndrome is most common in patients with which of the following hemoglobin genotypes?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following complications is not associated with recurrent acute chest syndrome?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Among patients with sickle cell anemia, which of the following factors is least likely to trigger acute chest syndrome?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
An 11-year-old African-American male with sickle cell disease is admitted for a pain crisis. He is on morphine patient-controlled analgesia with control of his extremity pain. His heart rate is 110, respiratory rate 32, and oxygen saturation is 84% on room air. He is afebrile. The patient has intercostal retractions and accessory muscle usage. He has an II/VI systolic murmur at the left sternal border, and his abdomen is soft and nontender. The most likely cause of his respiratory difficulties is which of the following?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the most common cause of acute chest syndrome in children?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
When should antibiotics be started in acute chest syndrome?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the goal of a simple transfusion in acute chest syndrome?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the most common cause of acute chest syndrome in adult patients?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 3-year-old girl with known past medical history of sickle cell disease (HbSS) presents to the emergency department with a cough. She has never had an episode of acute chest syndrome and has no other significant history. The patient appears comfortable. Her chest x-ray shows suspicion of left lower lobe early infiltrate. The patient is afebrile. What is the disposition from the emergency department?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Acute Chest Syndrome - References

References

Shome DK,Jaradat A,Mahozi AI,Sinan AS,Ebrahim A,Alrahim M,Ebraheem MS,Mansoor EJ,Majed KS,Azeez Pasha SA, The Platelet Count and its Implications in Sickle Cell Disease Patients Admitted for Intensive Care. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine. 2018 Aug     [PubMed]
Day ME,Rodeghier M,DeBaun MR, Children with HbSβ{sup}0{/sup} thalassemia have higher hemoglobin levels and lower incidence rate of acute chest syndrome compared to children with HbSS. Pediatric blood     [PubMed]
Porter M, Rapid Fire: Sickle Cell Disease. Emergency medicine clinics of North America. 2018 Aug     [PubMed]
da Cunha Gomes EG,Machado LAF,de Oliveira LC,Neto JFN, The erythrocyte alloimmunisation in patients with sickle cell anaemia: a systematic review. Transfusion medicine (Oxford, England). 2018 May 29     [PubMed]
Colla JS,Kotini-Shah P,Soppet S,Chen YF,Molokie R,Prajapati P,Prendergast HM, Use of bedside ultrasound as a predictive tool for acute chest syndrome in sickle cell patients: A prospective exploratory study. The American journal of emergency medicine. 2018 Jul 3     [PubMed]
Farooq S,Abu Omar M,Salzman GA, Acute chest syndrome in sickle cell disease. Hospital practice (1995). 2018 Aug     [PubMed]
Takahashi T,Okubo Y,Pereda MA,Handa A,Miller S, Factors Associated With Mechanical Ventilation Use in Children With Sickle Cell Disease and Acute Chest Syndrome. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2018 Sep     [PubMed]
Kato GJ,Piel FB,Reid CD,Gaston MH,Ohene-Frempong K,Krishnamurti L,Smith WR,Panepinto JA,Weatherall DJ,Costa FF,Vichinsky EP, Sickle cell disease. Nature reviews. Disease primers. 2018 Mar 15     [PubMed]
Du M,Van Ness S,Gordeuk V,Nouraie SM,Nekhai S,Gladwin M,Steinberg MH,Sebastiani P, Biomarker signatures of sickle cell disease severity. Blood cells, molecules     [PubMed]
Willen SM,Rodeghier M,Strunk RC,Bacharier LB,Rosen CL,Kirkham FJ,DeBaun MR,Cohen RT, Aeroallergen sensitization predicts acute chest syndrome in children with sickle cell anaemia. British journal of haematology. 2018 Feb     [PubMed]
Heilbronner C,Merckx A,Brousse V,Allali S,Hubert P,de Montalembert M,Lesage F, Early Noninvasive Ventilation and Nonroutine Transfusion for Acute Chest Syndrome in Sickle Cell Disease in Children: A Descriptive Study. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2018 May     [PubMed]
Chamba C,Iddy H,Tebuka E,Tluway F,Osati E,Budodi N,Meda C,Yonazi M,Schuh A,Luzzatto L,Makani J, Limited Exchange Transfusion Can Be Very Beneficial in Sickle Cell Anemia with Acute Chest Syndrome: A Case Report from Tanzania. Case reports in hematology. 2018     [PubMed]
Rees DC,Robinson S,Howard J, How I manage red cell transfusions in patients with sickle cell disease. British journal of haematology. 2018 Feb     [PubMed]
Jain S,Bakshi N,Krishnamurti L, Acute Chest Syndrome in Children with Sickle Cell Disease. Pediatric allergy, immunology, and pulmonology. 2017 Dec 1     [PubMed]
Ballas SK, From total blood exchange to erythrocytapheresis and back to treat complications of sickle cell disease. Transfusion. 2017 Sep     [PubMed]
Leonard A,Godiwala N,Herrera N,McCarter R,Sharron M,Meier ER, Early initiation of inhaled corticosteroids does not decrease acute chest syndrome morbidity in pediatric patients with sickle cell disease. Blood cells, molecules     [PubMed]
Sewaralthahab SS,Menaker J,Law JY, Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Anemia and Severe Acute Chest Syndrome. Hemoglobin. 2018 Jan     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Nurse-Child Health PN. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Nurse-Child Health PN, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Nurse-Child Health PN, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Nurse-Child Health PN. When it is time for the Nurse-Child Health PN board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Nurse-Child Health PN.